The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and ...

as well as Alphabet. Isomorphic's technology platform has already generated a number of AI models that are being applied to the discovery of new medicines, and it already counts Eli Lilly and ...

with participation from GV and existing investor Alphabet, Google’s parent, it said. The funding will accelerate further development of Isomorphic’s AI drug design engine and support ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

【Alphabet旗下Isomorphic Labs宣布获得6亿美元外部投资】财联社3月31日电，Alphabet的子公司Isomorphic Labs当地时间3月31日宣布已在其首轮外部融资中筹集到6亿美元。本轮融资由Thrive Capital领投，GV和现有投资者Alphabet跟投。

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment.